Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.
| Trivial name | Anti-alpha5beta1 integrin monoclonal antibody |
| Catalog Number | A3106 |
| CAS# | 558480-40-3 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/volociximab-anti-integrin-a5b1-itga5--itgb1.html |